Legislative Push to Automate Biosimilar Substitution and Lower Drug Costs

Proposed House and Senate legislation seeks to eliminate separate FDA interchangeability requirements, allowing pharmacies to automatically substitute lower-cost biosimilars for original biologics. These bills aim to reduce administrative red tape and accelerate patient access to affordable medicine.